NCT00000308

Dextroamphetamine-Cocaine Behavioral Intervention - 5

D-amphetamine-Cocaine Behavioral Intervention

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 54 (actual)
• Sponsor: National Institute on Drug Abuse (NIDA) · NIH
• Sex: All
• Age: 18 Years – 45 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to examine dextroamphetamine-cocaine behavioral intervention in cocaine dependent patients.

Conditions

• Cocaine-Related Disorders

Interventions

Type	Name	Description
DRUG	Dextroamphetamine	15 mg of d-amphetamine for first 8 weeks of study and 30 mg for the second 8 weeks
DRUG	D-amphetamine	15 mg of d-amphetamine for first 8 weeks of study and 30 mg for the second 8 weeks
DRUG	placebo	placebo

Timeline

• Start date: 1995-09-01
• Primary completion: 2000-09-01
• Completion: 2000-09-01
• First posted: 1999-09-21
• Last updated: 2017-01-12

Locations

1 site across 1 country: United States